I am a Neuroscientist and Postdoc at Washington University in St. Louis. My primary interest is in understanding how neurodevelopment mediates the effects of genetics and stress on the emergence of psychopathology, particularly substance use and depressive disorders. My research also includes work identifying replicable and reliable neural correlates of psychopathology, as well as work studying factors that influence the measurement of common neuroimaging metrics.
As a postdoc I have worked with Dr. Arpana Agrawal, Dr. Anna Manelis, and Dr. Erika Forbes. This work has focused on studying the reliability of neuroimaging measures of reward, identifying novel structural (cortical myelin) correlates of depression, and studying the association of depression with the neurodevelopment of reward function. My current work seeks to understand how genomic risk for substance use and depression influences neurodevelopment and the emergence of psychopathology in developing samples.
I completed my PhD in Neuroscience at Washington University in St Louis, where I worked with Dr. Ryan Bogdan and Dr. Deanna Barch. My dissertation was on the use of neural biomarkers to disentangle the causes and downstream consequences of alcohol use.
Outside of work you can find me playing with my cats, rock climbing, backpacking, and at indie/electronic shows.
How does journalism play a role in drugs and addiction? Eve Simmons is a British writer, journalist and health and wellness editor at DailyMail.com....
Brian Hurley, MD, MBA, DFASAM is an addiction physician and the Medical Director of the Division of Substance Abuse Prevention and Control in the...
Born and raised in Los Angeles, Richard Taite is the founder and Executive Chairman of Carrara Treatment Wellness & Spa, an “ultra” luxury addiction...